The pharmacological treatment of rat KCs with a PPARγ agonist (pioglitazone hydrochloride) inhibited nitric oxide (NO) and tumor necrosis factor-alpha (TNF-α) induced by LPS. Here, TNF is linked to dry eye syndrome.